BG63305B1 - Фармацевтични пиперазинови производни - Google Patents
Фармацевтични пиперазинови производни Download PDFInfo
- Publication number
- BG63305B1 BG63305B1 BG101601A BG10160197A BG63305B1 BG 63305 B1 BG63305 B1 BG 63305B1 BG 101601 A BG101601 A BG 101601A BG 10160197 A BG10160197 A BG 10160197A BG 63305 B1 BG63305 B1 BG 63305B1
- Authority
- BG
- Bulgaria
- Prior art keywords
- methyl
- piperazinylidene
- dioxy
- benzylidene
- methylbenzamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Electron Tubes For Measurement (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9426090.8A GB9426090D0 (en) | 1994-12-23 | 1994-12-23 | Pharmaceutical compounds |
| PCT/GB1995/003029 WO1996020180A1 (en) | 1994-12-23 | 1995-12-22 | Piperazine-2,5-dione derivatives as modulators of multidrug resistance |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BG101601A BG101601A (en) | 1998-02-27 |
| BG63305B1 true BG63305B1 (bg) | 2001-09-28 |
Family
ID=10766502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG101601A Active BG63305B1 (bg) | 1994-12-23 | 1997-06-11 | Фармацевтични пиперазинови производни |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US5935955A (xx) |
| EP (1) | EP0799210B1 (xx) |
| JP (1) | JPH10511385A (xx) |
| KR (1) | KR100412167B1 (xx) |
| CN (1) | CN1108294C (xx) |
| AT (1) | ATE204569T1 (xx) |
| AU (1) | AU700891B2 (xx) |
| BG (1) | BG63305B1 (xx) |
| BR (1) | BR9510429A (xx) |
| CA (1) | CA2207548A1 (xx) |
| CZ (1) | CZ288935B6 (xx) |
| DE (1) | DE69522342T2 (xx) |
| DK (1) | DK0799210T3 (xx) |
| ES (1) | ES2160726T3 (xx) |
| FI (1) | FI972661A (xx) |
| GB (2) | GB9426090D0 (xx) |
| HK (1) | HK1001974A1 (xx) |
| HU (1) | HUT77740A (xx) |
| IL (1) | IL116526A (xx) |
| MY (1) | MY131762A (xx) |
| NO (1) | NO308532B1 (xx) |
| NZ (1) | NZ297849A (xx) |
| PL (1) | PL186851B1 (xx) |
| PT (1) | PT799210E (xx) |
| SK (1) | SK283385B6 (xx) |
| UA (1) | UA61879C2 (xx) |
| WO (1) | WO1996020180A1 (xx) |
| ZA (1) | ZA9510908B (xx) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9708805D0 (en) | 1997-05-01 | 1997-06-25 | Smithkline Beecham Plc | Compounds |
| GB9810876D0 (en) | 1998-05-20 | 1998-07-22 | Smithkline Beecham Plc | Compounds |
| MA26696A1 (fr) | 1998-10-08 | 2004-12-20 | Smithkline Beecham Plc | Derives de tetrahydrobenzazepine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant |
| US6828412B1 (en) * | 1999-09-03 | 2004-12-07 | School Of Pharmacy, University Of London | Degradable polymers |
| AU7346400A (en) * | 1999-09-03 | 2001-04-10 | School Of Pharmacy, University Of London, The | Degradable polymers |
| CA2385528C (en) | 1999-10-01 | 2013-12-10 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| ATE377048T1 (de) | 2000-09-06 | 2007-11-15 | Ap Pharma Inc | Abbaubare polyacetal-polymere |
| US6693099B2 (en) | 2000-10-17 | 2004-02-17 | The Procter & Gamble Company | Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
| US20030109448A1 (en) * | 2001-11-07 | 2003-06-12 | Crowley Kathleen S. | Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells |
| US8710062B2 (en) * | 2011-03-11 | 2014-04-29 | Taipei Medical University | Piperazinedione compounds |
| CN103396372B (zh) * | 2013-08-09 | 2015-05-20 | 中国科学院南海海洋研究所 | 一类2,5-二酮哌嗪衍生物及其制备方法和在制备抗海洋污损生物防除剂中的应用 |
| AU2019416623B2 (en) * | 2018-12-27 | 2022-12-08 | Holosmedic | Novel compound and pharmaceutical composition comprising same for enhancing anticancer activity |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5663179A (en) * | 1992-07-10 | 1997-09-02 | Laboratoires Glaxo Sa | Certain isoquinoline derivatives having anti-tumor properties |
| GB9217331D0 (en) * | 1992-08-14 | 1992-09-30 | Xenova Ltd | Pharmaceutical compounds |
| US5460977A (en) * | 1992-08-14 | 1995-10-24 | Torii & Co. | Peptide having allergenicity |
| GB9402807D0 (en) * | 1994-02-14 | 1994-04-06 | Xenova Ltd | Pharmaceutical compounds |
| GB9410387D0 (en) * | 1994-05-24 | 1994-07-13 | Xenova Ltd | Pharmaceutical compounds |
-
1994
- 1994-12-23 GB GBGB9426090.8A patent/GB9426090D0/en active Pending
-
1995
- 1995-12-21 ZA ZA9510908A patent/ZA9510908B/xx unknown
- 1995-12-22 ES ES95941799T patent/ES2160726T3/es not_active Expired - Lifetime
- 1995-12-22 CA CA002207548A patent/CA2207548A1/en not_active Abandoned
- 1995-12-22 WO PCT/GB1995/003029 patent/WO1996020180A1/en active IP Right Grant
- 1995-12-22 NZ NZ297849A patent/NZ297849A/en unknown
- 1995-12-22 GB GB9712179A patent/GB2311780B/en not_active Expired - Fee Related
- 1995-12-22 CZ CZ19971902A patent/CZ288935B6/cs not_active IP Right Cessation
- 1995-12-22 UA UA97062956A patent/UA61879C2/uk unknown
- 1995-12-22 DE DE69522342T patent/DE69522342T2/de not_active Expired - Fee Related
- 1995-12-22 SK SK835-97A patent/SK283385B6/sk unknown
- 1995-12-22 CN CN95197673A patent/CN1108294C/zh not_active Expired - Fee Related
- 1995-12-22 HU HU9800446A patent/HUT77740A/hu unknown
- 1995-12-22 BR BR9510429A patent/BR9510429A/pt not_active Application Discontinuation
- 1995-12-22 PT PT95941799T patent/PT799210E/pt unknown
- 1995-12-22 AT AT95941799T patent/ATE204569T1/de not_active IP Right Cessation
- 1995-12-22 AU AU43102/96A patent/AU700891B2/en not_active Ceased
- 1995-12-22 JP JP8520303A patent/JPH10511385A/ja not_active Ceased
- 1995-12-22 US US08/860,328 patent/US5935955A/en not_active Expired - Fee Related
- 1995-12-22 EP EP95941799A patent/EP0799210B1/en not_active Expired - Lifetime
- 1995-12-22 DK DK95941799T patent/DK0799210T3/da active
- 1995-12-22 IL IL11652695A patent/IL116526A/xx not_active IP Right Cessation
- 1995-12-22 KR KR1019970704226A patent/KR100412167B1/ko not_active IP Right Cessation
- 1995-12-22 PL PL95320915A patent/PL186851B1/pl not_active IP Right Cessation
- 1995-12-23 MY MYPI95004072A patent/MY131762A/en unknown
-
1997
- 1997-06-11 BG BG101601A patent/BG63305B1/bg active Active
- 1997-06-19 FI FI972661A patent/FI972661A/fi not_active IP Right Cessation
- 1997-06-23 NO NO972938A patent/NO308532B1/no not_active IP Right Cessation
-
1998
- 1998-02-11 HK HK98101043A patent/HK1001974A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7501424B2 (en) | N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof | |
| AU2016292450B2 (en) | Aniline pyrimidine derivatives and uses thereof | |
| JPWO2009022731A1 (ja) | Ｐ２ｘ４受容体拮抗剤 | |
| BRPI0617364A2 (pt) | compostos heterocÍclicos como inibidores de pstat3/il-6 | |
| WO1996020190A1 (en) | Piperazine 2,5 dione derivatives as modulators of multi-drug resistance | |
| BG63305B1 (bg) | Фармацевтични пиперазинови производни | |
| US6407106B1 (en) | N-triazolylmethyl-piperazine compounds with neurokinin-receptor antagonist activity | |
| US6699861B1 (en) | Anti-quinazoline compounds | |
| CA2841897A1 (en) | Novel compound having parp inhibitory activity | |
| WO1996020179A1 (en) | Piperazine-2,5-dione derivatives as modulators of multi-drug resistance | |
| FR2643373A1 (fr) | Nouveaux derives des bisarylalcenes, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent | |
| KR20000029564A (ko) | 5ＨＴ2ｃ길항제및Ｄ2길항제를함유하는약제학적조성물 | |
| KR100608473B1 (ko) | α 1ａ 수용체 길항제로서의 프탈이미도 아릴피페라진 및 이를 포함하는 양성 전립선 과형성 치료용 약제학적 조성물 | |
| US5278158A (en) | Oxazinobenzazole compounds | |
| US5232922A (en) | Imidazole compounds, processes for their preparation, pharmaceuticals based on these compounds and some intermediates | |
| JP2000351773A (ja) | フラン誘導体からなる医薬 | |
| CZ327494A3 (en) | Esters of nicotinic acid and process for preparing thereof | |
| JPH03145464A (ja) | 光学活性１，４―ジヒドロピリジン誘導体 | |
| GB2324301A (en) | Pharmaceutically-active Piperazinedione Compounds | |
| JP3197495B2 (ja) | ピロリルベンズイミダゾール誘導体 | |
| CN111187262A (zh) | 咪唑并[1,2-a]吡啶衍生物及其制备方法和应用 | |
| WO2012036268A1 (ja) | グリシントランスポーター阻害物質 | |
| CZ278999A3 (cs) | 3-pyperidinyl-4-oxochinazolinové deriváty a farmaceutické prostředky, ve kterých jsou obsaženy |